Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bonichon

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
The American Journal of Pathology|June 1, 1997
Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate studyP Rudolph, U Kellner, A Chassevent, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 1997
Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinomaG MacGrogan, I Jollet, S Huet, et al.
British Journal of Cancer|November 1, 1996
Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST piG MacGrogan, L Mauriac, M Durand, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Distinct entities among low-grade non-Hodgkin's malignant lymphomas. Analysis of a series of 377 casesB Hoerni, M Trojani, H Eghbali, et al.
Cancer|July 24, 2001
Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma GroupE Stoeckle, J M Coindre, S Bonvalot, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|August 1, 1985
[The request for surgical biopsy in mammography. Apropos of 140 verified cases]M H Dilhuydy, J L Guibert, M Trojani, et al.
Breast Cancer Research and Treatment|January 1, 1995
Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 casesG MacGrogan, F Bonichon, I de Mascarel, et al.
Annales D'Endocrinologie|January 31, 2016
Local treatment of metastases from differentiated thyroid cancerF Bonichon, X Buy, Y Godbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)L Mauriac, G MacGrogan, A Avril, et al.
Bulletin Du Cancer|January 1, 1984
[Histological types of 876 breast cancers according to the 1981 WHO classification]M Trojani, I de Mascarel, J M Coindre, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
The American Journal of Pathology|June 1, 1997
Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate studyP Rudolph, U Kellner, A Chassevent, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 1997
Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinomaG MacGrogan, I Jollet, S Huet, et al.
British Journal of Cancer|November 1, 1996
Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST piG MacGrogan, L Mauriac, M Durand, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Distinct entities among low-grade non-Hodgkin's malignant lymphomas. Analysis of a series of 377 casesB Hoerni, M Trojani, H Eghbali, et al.
Cancer|July 24, 2001
Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma GroupE Stoeckle, J M Coindre, S Bonvalot, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|August 1, 1985
[The request for surgical biopsy in mammography. Apropos of 140 verified cases]M H Dilhuydy, J L Guibert, M Trojani, et al.
Breast Cancer Research and Treatment|January 1, 1995
Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 casesG MacGrogan, F Bonichon, I de Mascarel, et al.
Annales D'Endocrinologie|January 31, 2016
Local treatment of metastases from differentiated thyroid cancerF Bonichon, X Buy, Y Godbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)L Mauriac, G MacGrogan, A Avril, et al.
Bulletin Du Cancer|January 1, 1984
[Histological types of 876 breast cancers according to the 1981 WHO classification]M Trojani, I de Mascarel, J M Coindre, et al.
Pageof 11